)
Evolent Health (EVH) investor relations material
Evolent Health Piper Sandler 37th Annual Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Market trends and business performance
Specialty care management trends in oncology and cardiology are in line with expectations, with oncology trend just under 11% and cardiology slightly higher due to a benefits rush ahead of premium increases.
Two-thirds of revenue is tied to ACA Marketplace and Medicaid, with the remainder from Medicare Advantage; risk pool adjustments and a growing Medicare Advantage pipeline support forecasting.
Adherence to evidence-based pathways is increased from mid-60% to mid-80% within a few years, driving both quality and cost savings.
Oncology savings are primarily from matching therapeutics to patients, with additional savings in radiation and end-of-life care; cardiology savings focus on reducing or optimizing surgical interventions.
Independent oncology practices are slightly more open to innovation, but strong outcomes are achieved across both independent and large health systems.
Financial guidance and contract structure
2025 adjusted EBITDA is guided to $149 million, with 80% from tech and services and 20% from the Performance Suite; $10 million of this is from a divested asset, making the pro forma number $139 million.
Performance Suite contracts now include protections for case mix, acuity, new drugs, and price changes, with hard loss corridors in all contracts.
New Performance Suite contracts totaling $750 million in ACV are set to go live in 2026, with minimal EBITDA contribution initially and margins expected to reach 10% by mid-to-late 2028.
2025 Performance Suite EBITDA margin is expected at 3%, with care margin at 7% and administrative load at 4%; care margin is expected to improve by about 100 basis points as the business scales.
Fee-based adjusted EBITDA is expected to rebound in 2026, supported by new revenue launches and efficiency improvements, despite 2025 declines due to membership attrition and investments in AI.
Risk management and pricing
ACA Marketplace exposure is about 20% of revenue, with a downside scenario assuming 40%-60% shrinkage; EBITDA is expected to remain flat or grow modestly even in this scenario.
Pricing for 2026 Performance Suite business is designed to float with actual prevalence and case mix, allowing in-year adjustments to maintain margin alignment.
Next Evolent Health earnings date
Next Evolent Health earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)